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Overall  Research Goals:
• Test if NIAM is a chromatin associated protein in vivo
• Determine the biological role of dNIAM, a novel protein, in 
Drosophila melanogaster
Methods:Background & Significance:
• The novel protein known as NIAM (Nuclear Interactor 
of ARF and MDM2) functions to inhibit proliferation, 
bind chromatin in vitro and maintain chromosomal 
stability.1 NIAM contains FYRN/FYRC domains enriched 
in phenylalanine and tyrosine residues (50-100aa).2
• Many chromatin-associated proteins, particularly 
histone H3K4 methyltransferases, contain these 
FYRN/FYRC motifs.2 However, the function of these 
unique domains is not known.  
• Drosophila NIAM  (dNIAM) also retains FYRN/FYRC 
domains, which we predict associate with chromatin 
similarly to the mammalian form.
Future Directions:
• Construct mutant forms of dNIAM that lack FYRN/FYRC motifs and 
express in Drosophila
• Determine if FYRN/FYRC domains in dNIAM interact with chromatin 
modification machinery
• Determine if the FYRN/FYRC domains of NIAM are critical for 
chromatin association, chromosome stability and/or proliferation
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A) PCR amplified dNIAM cDNA using 
primers with 5’ EcoR1 and 3’ Age1
- Added A overhangs by Taq polymerase
B) Subcloned into pCRII-TOPO vector
- sequenced miniprep DNA
- digested recombinant plasmid to release the 
dNIAM insert
C) Cloned dNIAM cDNA into pEGFP 
vectors in order to form fusion 
constructs with GFP (dNIAM-GFP)
D) Digested and ligated dNIAM-GFP cDNA
into Drosophila melanogaster GAL4-UAS 
inducible expression vectors, which were 
subsequently injected into Drosphila larvae 
by a company to obtain in vivo expression 
(http://www.geneticservices/injectionservi
ces.htm) 
dNIAM
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Results: dNIAM-GFP is nuclear in human cells
(1) Western blotting confirmed appropriate size of dNIAM-GFP fusion protein 
when expressed in 293T mammalian cells
(2) Immmunfluorescence analysis in same cells  confirmed fusion protein 
localization in nucleus, as expected
Western Blot: Immunofluorescence Image:
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Results: dNIAM-GFP binds chromatin in 
vivo when expressed in flies
Transgenic fly stocks (from D) were generated and crossed to get dNIAM-
GFP expression.  Salivary glands were fixed, squashed and stained with 
antibodies to GFP. dNIAM-GFP localized to chromosomes in vivo
at decondensed regions of chromatin (no DAPI staining), 
consistent with a role in chromatin regulation.  
Other studies showed that loss of endogenous dNIAM by RNAi 
causes an over-proliferation phenotype in eyes
anti-GFP DAPI merge
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